gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · IVFHealthcareSurgical Instruments

INVO Fertility, Inc. Common Stock (IVF)

$2.05+5.67%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$2.05▼ 97.41% in range
Nov 4, 2025Low $1.83 · High $91.04Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

INVO Fertility closed at $2.05 on Nov 4, up 5.67%, 97.7% below its 52-week closing high. Volume of 40.9K shares was 0.41× its 20-day average (below normal).

Split-adjusted performance: -35.5% over one month, -71.7% over six months, -97.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $2.18M, up 16.7% from a year earlier, with a net margin of 40.9%.

Short interest was 26.5K shares at the Oct 15 settlement, down 47.2% from the prior report (1.1% of float, 1.0 days to cover).

Market cap$2.4M1.2M shares
Revenue · quarter$2.2M+16.7% YoY
Diluted EPS$1.40—
P/E · TTM—P/S 0.3×
Net margin40.9%Gross 35.1%
Dividend yieldNone
52-week range1.83 – 91.04−97.7% from high
Volume40.9K0.41× 20-day avg
Volatility · 60d432.1%Annualised
Short % of float1.1%1.0 days to cover
Net cash$2.1MCash $3.7M
Next earnings—Not scheduled
Split-adjusted performance
1W −7.8%1M −35.5%3M −50.7%6M −71.7%YTD −86.4%1Y −97.6%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum11
Revenue growth69
Net margin100
Value (low P/E)—
Size5

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short26.5K−47.2% vs prior
Days to cover1.0Settled Oct 15
% of float1.1%
Short vol. 10d33.7%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
IVFINVO Fertility$2.05+5.67%−71.7%+16.7%40.9%—$2.4M
ADGMAdagio Medical Holdings$0.08620.00%−91.1%———$2.4MCompare
XAIRBeyond Air$2.33+0.43%−79.4%+0.5%−448.8%—$2.3MCompare
VVOSVivos Therapeutics$0.1112+1.27%−84.6%+34.9%−106.4%—$2.2MCompare
BJDXBluejay Diagnostics$2.29+3.62%−69.7%———$2.6MCompare
NXGLNexGel$4.01−10.49%−66.6%+27.8%−98.6%—$2.0MCompare
AMIXAutonomix Medical$1.61−3.01%−80.1%———$3.2MCompare
CODXCo-Diagnostics$0.3614−4.89%—+2.0%−3782.4%—$3.2MCompare
AEMDAETHLON MEDICAL$5.75−0.86%−51.7%———$4.1MCompare

News about INVO Fertility

All news →
INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026GlobeNewswire Inc. · Oct 27, 2026▼ Negative

Quick answers

What does INVO Fertility do?
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell).
What is IVF's market cap?
$2.36M, based on the Nov 4 close of $2.05.
Does INVO Fertility pay a dividend?
No regular cash dividend has been paid in the last year.
How much of IVF is sold short?
26.5K shares, 1.1% of float, as of Oct 15, 2026.
What sector is IVF in?
Healthcare, in the Surgical Instruments industry.

About INVO Fertility

INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.

HQ: Sarasota, FL46 employeesListed Nov 11, 2008invobioscience.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology